1
|
Nazari-Vanani R, Kayani Z, Karimian K, Ajdari MR, Heli H. Development of New Nanoniosome Carriers for Vorinostat: Evaluation of Anticancer Efficacy In Vitro. J Pharm Sci 2024:S0022-3549(24)00199-0. [PMID: 38801974 DOI: 10.1016/j.xphs.2024.05.025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2024] [Revised: 05/20/2024] [Accepted: 05/20/2024] [Indexed: 05/29/2024]
Abstract
Vorinostat (VST) is a chemotherapeutic agent administrated for various types of cancers. However, it suffers from side effects and chemoresistance that reduce its application. Different nanoniosomes comprised Span 20, 60, 65 and 80 were prepared by the thin film hydration method and loaded with VST. The nanoniosomes were physicochemically characterized using particle size analysis and field emission scanning electron microscopy. The best formulation that was prepared using Span 65 (VST-NN-S65) included vesicle size of 127 nm with a narrow size distribution. VST-NN-S65 had an entrapment efficiency and loading capacity of 81.3 ± 5.1 and 32.0 ± 3.9 %, respectively. Drug release rate measurements showed that 90 % of VST was liberated within 1 h. Cytotoxicity assessments of VST-NN-S65 in HeLa and MCF7 cells indicated significant improvement in the effectiveness of VST, compared to the VST suspension. For VST-NN-S65, IC50 values of 26.3 and 6.6 μg mL-1 were obtained for HeLa and MCF7 cell lines, respectively. In situ apoptosis detection by the TUNEL assay revealed that apoptosis mainly occurred in the cell lines.
Collapse
Affiliation(s)
- R Nazari-Vanani
- Nanomedicine and Nanobiology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Z Kayani
- Nanomedicine and Nanobiology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| | - K Karimian
- Arasto Pharmaceutical Chemicals Inc., Yousefabad, Jahanarar Avenue, Tehran, Iran
| | - M R Ajdari
- Arasto Pharmaceutical Chemicals Inc., Yousefabad, Jahanarar Avenue, Tehran, Iran
| | - H Heli
- Nanomedicine and Nanobiology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
| |
Collapse
|
2
|
Xu X, Liu A, Liu S, Ma Y, Zhang X, Zhang M, Zhao J, Sun S, Sun X. Application of molecular dynamics simulation in self-assembled cancer nanomedicine. Biomater Res 2023; 27:39. [PMID: 37143168 PMCID: PMC10161522 DOI: 10.1186/s40824-023-00386-7] [Citation(s) in RCA: 6] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2022] [Accepted: 04/21/2023] [Indexed: 05/06/2023] Open
Abstract
Self-assembled nanomedicine holds great potential in cancer theragnostic. The structures and dynamics of nanomedicine can be affected by a variety of non-covalent interactions, so it is essential to ensure the self-assembly process at atomic level. Molecular dynamics (MD) simulation is a key technology to link microcosm and macroscale. Along with the rapid development of computational power and simulation methods, scientists could simulate the specific process of intermolecular interactions. Thus, some experimental observations could be explained at microscopic level and the nanomedicine synthesis process would have traces to follow. This review not only outlines the concept, basic principle, and the parameter setting of MD simulation, but also highlights the recent progress in MD simulation for self-assembled cancer nanomedicine. In addition, the physicochemical parameters of self-assembly structure and interaction between various assembled molecules under MD simulation are also discussed. Therefore, this review will help advanced and novice researchers to quickly zoom in on fundamental information and gather some thought-provoking ideas to advance this subfield of self-assembled cancer nanomedicine.
Collapse
Affiliation(s)
- Xueli Xu
- School of Science, Shandong Jianzhu University, Jinan, 250101, China
| | - Ao Liu
- School of Science, Shandong Jianzhu University, Jinan, 250101, China
| | - Shuangqing Liu
- School of Chemistry and Pharmaceutical Engineering, Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, 250000, China
| | - Yanling Ma
- School of Chemistry and Pharmaceutical Engineering, Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, 250000, China
| | - Xinyu Zhang
- School of Chemistry and Pharmaceutical Engineering, Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, 250000, China
| | - Meng Zhang
- School of Chemistry and Pharmaceutical Engineering, Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, 250000, China
| | - Jinhua Zhao
- School of Science, Shandong Jianzhu University, Jinan, 250101, China
| | - Shuo Sun
- Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, 02115, USA
| | - Xiao Sun
- School of Chemistry and Pharmaceutical Engineering, Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, 250000, China.
| |
Collapse
|
3
|
Taiariol L, Chaix C, Farre C, Moreau E. Click and Bioorthogonal Chemistry: The Future of Active Targeting of Nanoparticles for Nanomedicines? Chem Rev 2021; 122:340-384. [PMID: 34705429 DOI: 10.1021/acs.chemrev.1c00484] [Citation(s) in RCA: 63] [Impact Index Per Article: 21.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Over the years, click and bioorthogonal reactions have been the subject of considerable research efforts. These high-performance chemical reactions have been developed to meet requirements not often provided by the chemical reactions commonly used today in the biological environment, such as selectivity, rapid reaction rate, and biocompatibility. Click and bioorthogonal reactions have been attracting increasing attention in the biomedical field for the engineering of nanomedicines. In this review, we study a compilation of articles from 2014 to the present, using the terms "click chemistry and nanoparticles (NPs)" to highlight the application of this type of chemistry for applications involving NPs intended for biomedical applications. This study identifies the main strategies offered by click and bioorthogonal chemistry, with respect to passive and active targeting, for NP functionalization with specific and multiple properties for imaging and cancer therapy. In the final part, a novel and promising approach for "two step" targeting of NPs, called pretargeting (PT), is also discussed; the principle of this strategy as well as all the studies listed from 2014 to the present are presented in more detail.
Collapse
Affiliation(s)
- Ludivine Taiariol
- Université Clermont Auvergne, Imagerie Moléculaire et Stratégies Théranostiques, BP 184, F-63005 Clermont-Ferrand, France.,Inserm U 1240, F-63000 Clermont-Ferrand, France.,Centre Jean Perrin, F-63011 Clermont-Ferrand, France
| | - Carole Chaix
- Interfaces and Biosensors, UMR 5280, CNRS, F-69100 Villeurbanne, France.,Université de Lyon, CNRS, Université Claude Bernard Lyon 1, Institut des Sciences Analytiques, UMR 5280, 5 rue de la Doua, F-69100 Villeurbanne, France
| | - Carole Farre
- Interfaces and Biosensors, UMR 5280, CNRS, F-69100 Villeurbanne, France.,Université de Lyon, CNRS, Université Claude Bernard Lyon 1, Institut des Sciences Analytiques, UMR 5280, 5 rue de la Doua, F-69100 Villeurbanne, France
| | - Emmanuel Moreau
- Université Clermont Auvergne, Imagerie Moléculaire et Stratégies Théranostiques, BP 184, F-63005 Clermont-Ferrand, France.,Inserm U 1240, F-63000 Clermont-Ferrand, France.,Centre Jean Perrin, F-63011 Clermont-Ferrand, France
| |
Collapse
|
4
|
Bochkarev LN, Parshina YP, Gracheva YV, Kovylina TA, Lermontova SA, Klapshina LG, Konev AN, Lopatin MA, Lukina MM, Komarova AD, Shcheslavskiy VI, Shirmanova MV. Red Light-Emitting Water-Soluble Luminescent Iridium-Containing Polynorbornenes: Synthesis, Characterization and Oxygen Sensing Properties in Biological Tissues In Vivo. Molecules 2021; 26:6349. [PMID: 34770757 PMCID: PMC8587708 DOI: 10.3390/molecules26216349] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2021] [Revised: 10/12/2021] [Accepted: 10/18/2021] [Indexed: 11/16/2022] Open
Abstract
New water-soluble polynorbornenes P1-P4 containing oligoether, amino acid groups and luminophoric complexes of iridium(III) were synthesized by ring-opening metathesis polymerization. The polymeric products in organic solvents and in water demonstrate intense photoluminescence in the red spectral region. The polymers P1 and P3 with 1-phenylisoquinoline cyclometalating ligands in iridium fragments reveal 4-6 fold higher emission quantum yields in solutions than those of P2 and P4 that contain iridium complexes with 1-(thien-2-yl)isoquinoline cyclometalating ligands. The emission parameters of P1-P4 in degassed solutions essentially differ from those in the aerated solutions showing oxygen-dependent quenching of phosphorescence. Biological testing of P1 and P3 demonstrates that the polymers do not penetrate into live cultured cancer cells and normal skin fibroblasts and do not possess cytotoxicity within the concentrations and time ranges reasonable for biological studies. In vivo, the polymers display longer phosphorescence lifetimes in mouse tumors than in muscle, as measured using phosphorescence lifetime imaging (PLIM), which correlates with tumor hypoxia. Therefore, preliminary evaluation of the synthesized polymers shows their suitability for noninvasive in vivo assessments of oxygen levels in biological tissues.
Collapse
Affiliation(s)
- Leonid N. Bochkarev
- Razuvaev Institute of Organometallic Chemistry, Russian Academy of Sciences, Tropinina, 49, 603950 Nizhny Novgorod, Russia; (Y.P.P.); (Y.V.G.); (T.A.K.); (S.A.L.); (L.G.K.); (A.N.K.); (M.A.L.)
| | - Yulia P. Parshina
- Razuvaev Institute of Organometallic Chemistry, Russian Academy of Sciences, Tropinina, 49, 603950 Nizhny Novgorod, Russia; (Y.P.P.); (Y.V.G.); (T.A.K.); (S.A.L.); (L.G.K.); (A.N.K.); (M.A.L.)
| | - Yana V. Gracheva
- Razuvaev Institute of Organometallic Chemistry, Russian Academy of Sciences, Tropinina, 49, 603950 Nizhny Novgorod, Russia; (Y.P.P.); (Y.V.G.); (T.A.K.); (S.A.L.); (L.G.K.); (A.N.K.); (M.A.L.)
| | - Tatyana A. Kovylina
- Razuvaev Institute of Organometallic Chemistry, Russian Academy of Sciences, Tropinina, 49, 603950 Nizhny Novgorod, Russia; (Y.P.P.); (Y.V.G.); (T.A.K.); (S.A.L.); (L.G.K.); (A.N.K.); (M.A.L.)
| | - Svetlana A. Lermontova
- Razuvaev Institute of Organometallic Chemistry, Russian Academy of Sciences, Tropinina, 49, 603950 Nizhny Novgorod, Russia; (Y.P.P.); (Y.V.G.); (T.A.K.); (S.A.L.); (L.G.K.); (A.N.K.); (M.A.L.)
| | - Larisa G. Klapshina
- Razuvaev Institute of Organometallic Chemistry, Russian Academy of Sciences, Tropinina, 49, 603950 Nizhny Novgorod, Russia; (Y.P.P.); (Y.V.G.); (T.A.K.); (S.A.L.); (L.G.K.); (A.N.K.); (M.A.L.)
| | - Aleksey N. Konev
- Razuvaev Institute of Organometallic Chemistry, Russian Academy of Sciences, Tropinina, 49, 603950 Nizhny Novgorod, Russia; (Y.P.P.); (Y.V.G.); (T.A.K.); (S.A.L.); (L.G.K.); (A.N.K.); (M.A.L.)
| | - Mikhail A. Lopatin
- Razuvaev Institute of Organometallic Chemistry, Russian Academy of Sciences, Tropinina, 49, 603950 Nizhny Novgorod, Russia; (Y.P.P.); (Y.V.G.); (T.A.K.); (S.A.L.); (L.G.K.); (A.N.K.); (M.A.L.)
| | - Maria M. Lukina
- Institute of Experimental Oncology and Biomedical Technologies, Privolzhsky Research Medical University, Minin and Pozharsky Sq. 10/1, 603005 Nizhny Novgorod, Russia; (M.M.L.); (A.D.K.); (V.I.S.); (M.V.S.)
| | - Anastasia D. Komarova
- Institute of Experimental Oncology and Biomedical Technologies, Privolzhsky Research Medical University, Minin and Pozharsky Sq. 10/1, 603005 Nizhny Novgorod, Russia; (M.M.L.); (A.D.K.); (V.I.S.); (M.V.S.)
| | - Vladislav I. Shcheslavskiy
- Institute of Experimental Oncology and Biomedical Technologies, Privolzhsky Research Medical University, Minin and Pozharsky Sq. 10/1, 603005 Nizhny Novgorod, Russia; (M.M.L.); (A.D.K.); (V.I.S.); (M.V.S.)
- Becker&Hickl GmbH, Nunsdorfer Ring 7-9, 12277 Berlin, Germany
| | - Marina V. Shirmanova
- Institute of Experimental Oncology and Biomedical Technologies, Privolzhsky Research Medical University, Minin and Pozharsky Sq. 10/1, 603005 Nizhny Novgorod, Russia; (M.M.L.); (A.D.K.); (V.I.S.); (M.V.S.)
| |
Collapse
|
5
|
|
6
|
Tu B, Zhang M, Liu T, Huang Y. Nanotechnology-Based Histone Deacetylase Inhibitors for Cancer Therapy. Front Cell Dev Biol 2020; 8:400. [PMID: 32582697 PMCID: PMC7284110 DOI: 10.3389/fcell.2020.00400] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/07/2020] [Accepted: 05/01/2020] [Indexed: 12/19/2022] Open
Abstract
Histone deacetylase inhibitors (HDACi) have been approved and achieved success in hematologic malignancies. But its application in solid tumors still confronts big challenges and is hampered by low treatment efficacy. Nanotechnology has been widely applied in cancer therapy, and nanomedicine could improve drug stability, prolong the circulation half-life, and increase intratumoral drug accumulation. Therefore, nanomedicine is a promising strategy to enhance HDACi therapy efficacy. The review provides a summary of the advances of HDACi nanomedicines with a focus on the design principles of the targeting delivery systems for HDACi.
Collapse
Affiliation(s)
- Bin Tu
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.,University of Chinese Academy of Sciences, Beijing, China
| | - Meng Zhang
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
| | - Tuanbing Liu
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
| | - Yongzhuo Huang
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.,University of Chinese Academy of Sciences, Beijing, China.,NMPA Key Laboratory for Quality Research and Evaluation of Pharmaceutical Excipients, Beijing, China
| |
Collapse
|
7
|
The ROMP: A Powerful Approach to Synthesize Novel pH-Sensitive Nanoparticles for Tumor Therapy. Biomolecules 2019; 9:biom9020060. [PMID: 30759891 PMCID: PMC6406258 DOI: 10.3390/biom9020060] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2018] [Revised: 12/19/2018] [Accepted: 02/11/2019] [Indexed: 01/07/2023] Open
Abstract
Fast clearance, metabolism, and systemic toxicity are major limits for the clinical use of anti-cancer drugs. Histone deacetylase inhibitors (HDACi) present these defects, despite displaying promising anti-tumor properties on tumor cells in vitro and in in vivo models of cancer. The specific delivery of anti-cancer drugs into the tumor should improve their clinical benefit by limiting systemic toxicity and by increasing the anti-tumor effect. This paper deals with the synthesis of the polymeric nanoparticle platform, which was produced by Ring-Opening Metathesis Polymerization (ROMP), able to release anti-cancer drugs in dispersion, such as histone deacetylase inhibitors, into mesothelioma tumors. The core-shell nanoparticles (NPs) have stealth properties due to their poly(ethylene oxide) shell and can be viewed as universal nano-carriers on which any alkyne-modified anti-cancer molecule can be grafted by click chemistry. A cleavage reaction of the chemical bond between NPs and drugs through the contact of NPs with a medium presenting an acidic pH, which is typically a cancer tumor environment or an acidic intracellular compartment, induces a controlled release of the bioactive molecule in its native form. In our in vivo syngeneic model of mesothelioma, a highly selective accumulation of the particles in the tumor was obtained. The release of the drugs led to an 80% reduction of tumor weight for the best compound without toxicity. Our work demonstrates that the use of theranostic nanovectors leads to an optimized delivery of epigenetic inhibitors in tumors, which improves their anti-tumor properties in vivo.
Collapse
|
8
|
Belkahla H, Herlem G, Picaud F, Gharbi T, Hémadi M, Ammar S, Micheau O. TRAIL-NP hybrids for cancer therapy: a review. NANOSCALE 2017; 9:5755-5768. [PMID: 28443893 DOI: 10.1039/c7nr01469d] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
Cancer is a worldwide health problem. It is now considered as a leading cause of morbidity and mortality in developed countries. In the last few decades, considerable progress has been made in anti-cancer therapies, allowing the cure of patients suffering from this disease, or at least helping to prolong their lives. Several cancers, such as those of the lung and pancreas, are still devastating in the absence of therapeutic options. In the early 90s, TRAIL (Tumor Necrosis Factor-related apoptosis-inducing ligand), a cytokine belonging to the TNF superfamily, attracted major interest in oncology owing to its selective anti-tumor properties. Clinical trials using soluble TRAIL or antibodies targeting the two main agonist receptors (TRAIL-R1 and TRAIL-R2) have, however, failed to demonstrate their efficacy in the clinic. TRAIL is expressed on the surface of natural killer or CD8+ T activated cells and contributes to tumor surveillance. Nanoparticles functionalized with TRAIL mimic membrane-TRAIL and exhibit stronger antitumoral properties than soluble TRAIL or TRAIL receptor agonist antibodies. This review provides an update on the association and the use of nanoparticles associated with TRAIL for cancer therapy.
Collapse
Affiliation(s)
- H Belkahla
- Nanomedicine Lab, EA 4662, Université de Bourgogne Franche-Comté, Besançon, France
| | | | | | | | | | | | | |
Collapse
|
9
|
Yan Y, Yang Q, Wang J, Jin H, Wang J, Yang H, Zhou Z, Tian Q, Yang S. Heteropoly blue doped polymer nanoparticles: an efficient theranostic agent for targeted photoacoustic imaging and near-infrared photothermal therapy in vivo. J Mater Chem B 2017; 5:382-387. [DOI: 10.1039/c6tb02652d] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
We report a two-step process to construct heteropoly blue (HPB) doped polymer nanoparticles with efficient near-infrared (NIR) light absorption and photothermal conversion efficiency of ∼23%.
Collapse
Affiliation(s)
- Yuping Yan
- The Key Laboratory of Resource Chemistry of Ministry of Education
- Shanghai Key Laboratory of Rare Earth Functional Materials, and Shanghai Municipal Education Committee Key Laboratory of Molecular Imaging Probes and Sensors
- Shanghai Normal University
- Shanghai 200234
- China
| | - Qi Yang
- The Key Laboratory of Resource Chemistry of Ministry of Education
- Shanghai Key Laboratory of Rare Earth Functional Materials, and Shanghai Municipal Education Committee Key Laboratory of Molecular Imaging Probes and Sensors
- Shanghai Normal University
- Shanghai 200234
- China
| | - Jie Wang
- The Key Laboratory of Resource Chemistry of Ministry of Education
- Shanghai Key Laboratory of Rare Earth Functional Materials, and Shanghai Municipal Education Committee Key Laboratory of Molecular Imaging Probes and Sensors
- Shanghai Normal University
- Shanghai 200234
- China
| | - Hongyu Jin
- The Key Laboratory of Resource Chemistry of Ministry of Education
- Shanghai Key Laboratory of Rare Earth Functional Materials, and Shanghai Municipal Education Committee Key Laboratory of Molecular Imaging Probes and Sensors
- Shanghai Normal University
- Shanghai 200234
- China
| | - Jing Wang
- The Key Laboratory of Resource Chemistry of Ministry of Education
- Shanghai Key Laboratory of Rare Earth Functional Materials, and Shanghai Municipal Education Committee Key Laboratory of Molecular Imaging Probes and Sensors
- Shanghai Normal University
- Shanghai 200234
- China
| | - Hong Yang
- The Key Laboratory of Resource Chemistry of Ministry of Education
- Shanghai Key Laboratory of Rare Earth Functional Materials, and Shanghai Municipal Education Committee Key Laboratory of Molecular Imaging Probes and Sensors
- Shanghai Normal University
- Shanghai 200234
- China
| | - Zhiguo Zhou
- The Key Laboratory of Resource Chemistry of Ministry of Education
- Shanghai Key Laboratory of Rare Earth Functional Materials, and Shanghai Municipal Education Committee Key Laboratory of Molecular Imaging Probes and Sensors
- Shanghai Normal University
- Shanghai 200234
- China
| | - Qiwei Tian
- The Key Laboratory of Resource Chemistry of Ministry of Education
- Shanghai Key Laboratory of Rare Earth Functional Materials, and Shanghai Municipal Education Committee Key Laboratory of Molecular Imaging Probes and Sensors
- Shanghai Normal University
- Shanghai 200234
- China
| | - Shiping Yang
- The Key Laboratory of Resource Chemistry of Ministry of Education
- Shanghai Key Laboratory of Rare Earth Functional Materials, and Shanghai Municipal Education Committee Key Laboratory of Molecular Imaging Probes and Sensors
- Shanghai Normal University
- Shanghai 200234
- China
| |
Collapse
|
10
|
Janicka M, Gubernator J. Use of nanotechnology for improved pharmacokinetics and activity of immunogenic cell death inducers used in cancer chemotherapy. Expert Opin Drug Deliv 2016; 14:1059-1075. [DOI: 10.1080/17425247.2017.1266333] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Affiliation(s)
- Martyna Janicka
- Faculty of Biotechnology, Department of Lipids and Liposomes, University of Wroclaw, Wroclaw, Poland
| | - Jerzy Gubernator
- Faculty of Biotechnology, Department of Lipids and Liposomes, University of Wroclaw, Wroclaw, Poland
| |
Collapse
|
11
|
Neqal M, Pichavant L, Gauthier M, Héroguez V. Plurifunctional polyglycidol-based particles prepared by Dispersion Ring-Opening Metathesis Polymerization. Colloids Surf A Physicochem Eng Asp 2016. [DOI: 10.1016/j.colsurfa.2016.04.056] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
12
|
Han L, Wang T, Wu J, Yin X, Fang H, Zhang N. A facile route to form self-carried redox-responsive vorinostat nanodrug for effective solid tumor therapy. Int J Nanomedicine 2016; 11:6003-6022. [PMID: 27956831 PMCID: PMC5113930 DOI: 10.2147/ijn.s118727] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022] Open
Abstract
Small molecule-based nanodrugs with nanoparticles (NPs) that are mainly composed of small molecules, have been considered as a promising candidate for a next-generation nanodrug, owing to their unique properties. Vorinostat (SAHA) is a canonical US Food and Drug Administration-approved histone deacetylase (HDAC) inhibitor for the treatment of cutaneous T-cell lymphoma. However, the lack of efficacy against solid tumors hinders its progress in clinical use. Herein, a novel nanodrug of SAHA was developed based on disulfide-linked prodrug SAHA-S-S-VE. SAHA-S-S-VE could self-assemble into 148 nm NPs by disulfide-induced mechanisms, which were validated by molecular dynamics simulations. Under reduced conditions, the redox-responsive behavior of SAHA-S-S-VE was investigated, and the HDAC inhibition results verified the efficient release of free SAHA. With a biocompatible d-a-tocopheryl polyethylene glycol succinate (TPGS) functionalization, the SAHA-S-S-VE/TPGS NPs exhibited low critical aggregation concentration of 4.5 μM and outstanding stability in vitro with drug-loading capacity of 24%. In vitro biological assessment indicated that SAHA-S-S-VE/TPGS NPs had significant anticancer activity against HepG2. Further in vivo evaluation demonstrated that the resulting NPs could be accumulated in the tumor region and inhibit the tumor growth effectively. This approach, which turned SAHA into a self-assembled redox-responsive nanodrug, provided a new channel for the use of HDAC inhibitor in solid tumor therapy.
Collapse
Affiliation(s)
- Leiqiang Han
- School of Pharmaceutical Science, Shandong University, Ji'nan, Shandong, People's Republic of China
| | - Tianqi Wang
- School of Pharmaceutical Science, Shandong University, Ji'nan, Shandong, People's Republic of China
| | - Jingliang Wu
- School of Pharmaceutical Science, Shandong University, Ji'nan, Shandong, People's Republic of China
| | - Xiaolan Yin
- School of Pharmaceutical Science, Shandong University, Ji'nan, Shandong, People's Republic of China
| | - Hao Fang
- School of Pharmaceutical Science, Shandong University, Ji'nan, Shandong, People's Republic of China
| | - Na Zhang
- School of Pharmaceutical Science, Shandong University, Ji'nan, Shandong, People's Republic of China
| |
Collapse
|
13
|
Rubio-Ruiz B, Weiss JT, Unciti-Broceta A. Efficient Palladium-Triggered Release of Vorinostat from a Bioorthogonal Precursor. J Med Chem 2016; 59:9974-9980. [DOI: 10.1021/acs.jmedchem.6b01426] [Citation(s) in RCA: 73] [Impact Index Per Article: 9.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
Affiliation(s)
- Belén Rubio-Ruiz
- Cancer Research
UK Edinburgh Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Crewe Road South, Edinburgh EH4 2XR, U.K
| | - Jason T. Weiss
- Cancer Research
UK Edinburgh Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Crewe Road South, Edinburgh EH4 2XR, U.K
| | - Asier Unciti-Broceta
- Cancer Research
UK Edinburgh Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Crewe Road South, Edinburgh EH4 2XR, U.K
| |
Collapse
|
14
|
Pushpamalar J, Veeramachineni AK, Owh C, Loh XJ. Biodegradable Polysaccharides for Controlled Drug Delivery. Chempluschem 2016; 81:504-514. [DOI: 10.1002/cplu.201600112] [Citation(s) in RCA: 73] [Impact Index Per Article: 9.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2016] [Revised: 04/30/2016] [Indexed: 12/11/2022]
Affiliation(s)
| | | | - Cally Owh
- Institute of Materials Research and Engineering (IMRE); A*STAR; 3 Research Link Singapore 117602 Singapore
| | - Xian Jun Loh
- Institute of Materials Research and Engineering (IMRE); A*STAR; 3 Research Link Singapore 117602 Singapore
- Department of Materials Science and Engineering; National University of Singapore; 9 Engineering Drive 1 Singapore 117576 Singapore
- Singapore Eye Research Institute; 11 Third Hospital Avenue Singapore 168751 Singapore
| |
Collapse
|
15
|
The chemistry of the carbon-transition metal double and triple bond: Annual survey covering the year 2014. Coord Chem Rev 2016. [DOI: 10.1016/j.ccr.2015.09.012] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
16
|
Bahhaj FE, Denis I, Pichavant L, Delatouche R, Collette F, Linot C, Pouliquen D, Grégoire M, Héroguez V, Blanquart C, Bertrand P. Histone Deacetylase Inhibitors Delivery using Nanoparticles with Intrinsic Passive Tumor Targeting Properties for Tumor Therapy. Am J Cancer Res 2016; 6:795-807. [PMID: 27162550 PMCID: PMC4860888 DOI: 10.7150/thno.13725] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2015] [Accepted: 12/31/2015] [Indexed: 01/14/2023] Open
Abstract
Fast clearance, metabolism and systemic toxicity are major limits for the clinical use of anti-cancer drugs. Histone deacetylase inhibitors (HDACi) present these defects despite displaying promising anti-tumor properties on tumor cells in vitro and in in vivo model of cancers. Specific delivery of anti-cancer drugs into the tumor should improve their clinical benefit by limiting systemic toxicity and by increasing the anti-tumor effect. In this work, we describe a simple and flexible polymeric nanoparticle platform highly targeting the tumor in vivo and triggering impressive tumor weight reduction when functionalized with HDACi. Our nanoparticles were produced by Ring-Opening Metathesis Polymerization of azido-polyethylene oxide-norbornene macromonomers and functionalized using click chemistry. Using an orthotopic model of peritoneal invasive cancer, a highly selective accumulation of the particles in the tumor was obtained. A combination of epigenetic drugs involving a pH-responsive histone deacetylase inhibitor (HDACi) polymer conjugated to these particles gave 80% reduction of tumor weight without toxicity whereas the free HDACi has no effect. Our work demonstrates that the use of a nanovector with theranostic properties leads to an optimized delivery of potent HDACi in tumor and then, to an improvement of their anti-tumor properties in vivo.
Collapse
|
17
|
Pichavant L, Carrié H, Nguyen MN, Plawinski L, Durrieu MC, Héroguez V. Vancomycin Functionalized Nanoparticles for Bactericidal Biomaterial Surfaces. Biomacromolecules 2016; 17:1339-46. [PMID: 26938371 DOI: 10.1021/acs.biomac.5b01727] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
In this paper, we describe a simple and powerful way to synthesize antibacterial biomaterials with applications as implants in orthopedic surgery. Such implants are obtained by covalently grafting onto the Ti90A16 V4 alloy surface with vancomycin-functionalized nanoparticles. Nanoparticles were produced by ring-opening metathesis polymerization of α-norbornenyl-ω-vancomycin poly(ethylene oxide) macromonomers. Vancomycin is an interesting candidate because of its use in the field of implant associated infection as it is a glycopeptide which acts on bacterial walls. As a consequence, vancomycin does not need to be released for it to be active. In the first part of this paper, the synthesis and the complete characterization of these materials are described. In a second part, the in vitro antibacterial behavior is analyzed and discussed.
Collapse
Affiliation(s)
- Loïc Pichavant
- CNRS UMR5629, Laboratoire de Chimie des Polymères Organiques, IPB-ENSCBP, Université de Bordeaux, 16 avenue Pey Berland, F-33607 Pessac, France.,CNRS UMR5248, Institut de Chimie & Biologie des Membranes & des Nanoobjets, Université de Bordeaux, INP Bordeaux, 2 rue Robert Escarpit, F-33607 cedex Pessac France
| | - Hélène Carrié
- CNRS UMR5629, Laboratoire de Chimie des Polymères Organiques, IPB-ENSCBP, Université de Bordeaux, 16 avenue Pey Berland, F-33607 Pessac, France.,CNRS UMR5248, Institut de Chimie & Biologie des Membranes & des Nanoobjets, Université de Bordeaux, INP Bordeaux, 2 rue Robert Escarpit, F-33607 cedex Pessac France
| | - Minh Ngoc Nguyen
- CNRS UMR5629, Laboratoire de Chimie des Polymères Organiques, IPB-ENSCBP, Université de Bordeaux, 16 avenue Pey Berland, F-33607 Pessac, France.,Faculty of Chemistry, VNU University of Science , Hanoi, 19 Le Thanh Tong, Hoan Kiem, Hanoi, Vietnam
| | - Laurent Plawinski
- CNRS UMR5248, Institut de Chimie & Biologie des Membranes & des Nanoobjets, Université de Bordeaux, INP Bordeaux, 2 rue Robert Escarpit, F-33607 cedex Pessac France
| | - Marie-Christine Durrieu
- CNRS UMR5248, Institut de Chimie & Biologie des Membranes & des Nanoobjets, Université de Bordeaux, INP Bordeaux, 2 rue Robert Escarpit, F-33607 cedex Pessac France
| | - Valérie Héroguez
- CNRS UMR5629, Laboratoire de Chimie des Polymères Organiques, IPB-ENSCBP, Université de Bordeaux, 16 avenue Pey Berland, F-33607 Pessac, France
| |
Collapse
|
18
|
Senevirathne SA, Washington KE, Biewer MC, Stefan MC. PEG based anti-cancer drug conjugated prodrug micelles for the delivery of anti-cancer agents. J Mater Chem B 2016; 4:360-370. [DOI: 10.1039/c5tb02053k] [Citation(s) in RCA: 46] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
Abstract
Development of polymer prodrug conjugates has evolved recently in the nano-medicine field for cancer diagnosis and treatment. This review focuses on the development of different types of PEG based polymer drug conjugates used for the delivery of anti-cancer agents.
Collapse
|
19
|
Pichavant L, Carrié H, Durrieu MC, Héroguez V. Nanoparticles highly loaded with gentamicin sulfate by a combination of polyhydroxylated macromonomers and ROMP for the synthesis of bioactive biomaterials. Polym Chem 2016. [DOI: 10.1039/c6py01774f] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Nanoparticles highly loaded with gentamicin sulfate were synthesized by ring-opening metathesis copolymerization in a dispersion of norbornene with modified polyhydroxylated macromonomers.
Collapse
Affiliation(s)
- L. Pichavant
- Université de Bordeaux
- LCPO
- UMR5629
- F-33600 Pessac
- France
| | - H. Carrié
- Université de Bordeaux
- LCPO
- UMR5629
- F-33600 Pessac
- France
| | | | - V. Héroguez
- Université de Bordeaux
- LCPO
- UMR5629
- F-33600 Pessac
- France
| |
Collapse
|
20
|
Kapadia CH, Perry JL, Tian S, Luft JC, DeSimone JM. Nanoparticulate immunotherapy for cancer. J Control Release 2015; 219:167-180. [DOI: 10.1016/j.jconrel.2015.09.062] [Citation(s) in RCA: 59] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2015] [Revised: 09/25/2015] [Accepted: 09/28/2015] [Indexed: 12/11/2022]
|
21
|
Miki K, Kimura A, Inoue T, Matsuoka H, Harada H, Hiraoka M, Ohe K. Synthesis of Biocompatible Polysaccharide Analogues and Their Application to In Vivo Optical Tumor Imaging. BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN 2015. [DOI: 10.1246/bcsj.20150038] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
Affiliation(s)
- Koji Miki
- Department of Energy and Hydrocarbon Chemistry, Graduate School of Engineering, Kyoto University
| | - Akinori Kimura
- Department of Energy and Hydrocarbon Chemistry, Graduate School of Engineering, Kyoto University
| | - Tatsuhiro Inoue
- Department of Energy and Hydrocarbon Chemistry, Graduate School of Engineering, Kyoto University
| | - Hideki Matsuoka
- Department of Polymer Chemistry, Graduate School of Engineering, Kyoto University
| | - Hiroshi Harada
- Department of Radiation Oncology and Image-applied Therapy, Graduate School of Medicine, Kyoto University
- Precursory Research for Embryonic Science and Technology (PRESTO), Japan Science and Technology Agency (JST)
| | - Masahiro Hiraoka
- Department of Radiation Oncology and Image-applied Therapy, Graduate School of Medicine, Kyoto University
| | - Kouichi Ohe
- Department of Energy and Hydrocarbon Chemistry, Graduate School of Engineering, Kyoto University
| |
Collapse
|
22
|
Miki K. Synthesis and Functionalization of Polysaccharide Analogues and Their Application to High-Contrast Tumor Imaging. J SYN ORG CHEM JPN 2015. [DOI: 10.5059/yukigoseikyokaishi.73.580] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- Koji Miki
- Graduate School of Engineering, Kyoto University
| |
Collapse
|